Biomarkers

Autism Psychopharmacology

Learn current perspectives on psychopharmacology and autism from Dr. M. Pilar Trelles, MD, of Boston Children's Hospital. Handouts are online HERE (PDF file

Autism Psychopharmacology2025-09-24T16:01:20-05:00

Improving Clinical Understanding of Autism

James McPartland, Ph.D., discusses current limitations in autism diagnosis and treatment, noting their reliance on behavioral observations despite the condition's genetic and neurological underpinnings. He advocates integrating

Improving Clinical Understanding of Autism2025-09-11T12:50:54-05:00

Disordered Eating and Autism – Obesity

Francesca Solmi, Ph.D., discusses the intricate link between autism and eating disorders. She outlines common eating disorders, noting their overlapping symptoms and similarities to autism traits. The

Disordered Eating and Autism – Obesity2025-09-11T12:49:35-05:00

The autism-associated 16p11.2 microdeletion variant impacts the effects of microbiota disturbances on hippocampal development and behavior throughout the lifespan

Handouts are online HERE Approximately 17% of children are diagnosed with NDDs, including ASD, ADHD, and ID, which are highly heterogenous, frequently co-occur, and manifest in

The autism-associated 16p11.2 microdeletion variant impacts the effects of microbiota disturbances on hippocampal development and behavior throughout the lifespan2025-05-28T22:09:35-05:00
Go to Top